| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0004 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.37 | 0.0004 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.24 | 0.0006 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0009 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.15 | 0.001 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.002 |